COVID-19 and the malaria elimination agenda in Africa: Re-shifting the focus

Patrick, Sean; Cox, Sarah N; Guidera, Kathryn E.; Simon, Molly J.; Kruger, Taneshka; Bornman, Riana

doi:10.1080/17441692.2022.2129729

Cited by 2 publications

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From our study, the most likely reason for this lack of initiation was the complexity [ 55 , 56 ] of the recommendations required including the need to coordinate with the prequalification unit for tafenoquine because of requirement for its use with an appropriate near patient G6PD test (as per the drug manufacturer’s instructions). COVID related delays for policy change were also mentioned by respondents; similar delays and loss of priority and progress in malaria interventions due to COVID have been identified in Africa [ 57 ]. Other potential reasons identified from our study and other literature are organisational resistance to change (including policy decision-makers’ leadership and prioritisation approaches) and need for an appropriate opportunity to change policy (including donor support) [ 55 , 56 , 58 , 59 ].…”

Section: Discussionmentioning

confidence: 81%

Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria

Ruwanpura,

Grietens,

Price

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

Health policy processes should be evidence-informed, transparent and timely, but these processes are often unclear to stakeholders outside the immediate policymaking environment. We spoke to 36 international malaria stakeholders to gain insights on the processes involved in the World Health Organization’s Global Malaria Programme’s recommendations for their treatment guidelines of P. vivax malaria. Four key themes which drew on the 3i policy framework and Shiffman’s four factors that influence global and national policymaking were identified to understand these processes. Triggers for policy change and change prioritisation, evidence types that inform policy, effects of funding on decision-making processes, and transparency and communication of these processes to external stakeholders. Results indicate that more clarity is needed on what triggers global malaria policy change processes, a clearer justification of evidence types used to inform policymaking, better understanding of the impact of the WHO’s funding model on policymaking and further transparency and improved communication of these processes to external stakeholders is also needed. We suggest that global malaria policymaking could be improved by using the following strategies: ensuring that identified triggers actually initiate the policy change process, expediting decision-making timelines by developing a priority framework for assessing new evidence, adopting suitable frameworks to assess contextual evidence, and increasing the transparency of the role of non-state funders in policy decision-making processes and when publishing new recommendations.

show abstract

Section: Discussionmentioning

confidence: 81%

Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria

Ruwanpura,

Grietens,

Price

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

show abstract

Évoquer et traiter en temps et en heure le paludisme

Bouzid,

Houzé,

Thellier

et al. 2023

Ann. Fr. Med. Urgence

View full text Add to dashboard Cite

Le paludisme est une urgence médicale qui tue une vingtaine de personnes chaque année en France. Les services d’urgences adultes et pédiatriques sont en première ligne pour son diagnostic ainsi que pour l’évaluation de la gravité des cas dont dépendent le choix du traitement initial et la décision finale d’orientation (traitement ambulatoire, admission en médecine, admission en réanimation). Intégrer le patient à sa sortie des urgences dans une filière de soins adaptée à son état clinique et à son contexte personnel et social est essentiel à la qualité des soins et à la sécurité du patient. Mais l’organisation adéquate du parcours clinique du patient au sein du service d’urgences est également essentielle. Nous présentons ici un rappel des principales difficultés diagnostiques et thérapeutiques du paludisme, et des outils d’aide au diagnostic et à la décision thérapeutique à mettre en place dans les services d’urgences afin d’améliorer la qualité et la sécurité des soins des patients.

show abstract

COVID-19 and the malaria elimination agenda in Africa: Re-shifting the focus

Cited by 2 publications

References 43 publications

Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria

Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria

Évoquer et traiter en temps et en heure le paludisme

Contact Info

Product

Resources

About